Terrence Kearney
Keine laufenden Positionen mehr
Vermögen: 3 Mio $ am 30.04.2024
Profil
Terrence C.
Kearney served as an Independent Director at Acceleron Pharma, Inc. from 2014 to 2021.
He also held the position of Independent Director at Innoviva, Inc. from 2014 to 2016.
From 2016 to 2018, he served as an Independent Director at Novartis Gene Therapies, Inc. Mr. Kearney was a Director at Levo Therapeutics, Inc. from 2018 to 2022.
Prior to these roles, he served as an Independent Director at Vertex Pharmaceuticals, Inc. from 2011 to 2024.
Mr. Kearney's former job history also includes serving as Treasurer & Vice President at Abbott Laboratories from 2001 to 2004 and as Chief Operating Officer at Hospira, Inc. from 2006 to 2011.
He completed his undergraduate studies at the University of Illinois and holds an MBA from the University of Denver.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.05.2024 | 6 536 ( 0,00% ) | 3 Mio $ | 30.04.2024 |
Ehemalige bekannte Positionen von Terrence Kearney
| Unternehmen | Position | Ende |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Direktor/Vorstandsmitglied | 15.05.2024 |
Levo Therapeutics, Inc.
 Levo Therapeutics, Inc. BiotechnologyHealth Technology Levo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Glenview, IL. | Direktor/Vorstandsmitglied | 01.06.2022 |
| ACCELERON PHARMA INC. | Direktor/Vorstandsmitglied | 19.11.2021 |
| AVEXIS INC | Direktor/Vorstandsmitglied | 14.05.2018 |
| INNOVIVA, INC. | Direktor/Vorstandsmitglied | 26.04.2016 |
Ausbildung von Terrence Kearney
| University of Illinois | Undergraduate Degree |
| University of Denver | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| INNOVIVA, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Hospira, Inc.
 Hospira, Inc. Pharmaceuticals: MajorHealth Technology Hospira, Inc. provides injectable drugs and infusion technologies. It offers drugs, IV sets and clinical integration, infusion pumps, clinical software and implementation services. The company was founded on September 16, 2003 and is headquartered in Lake Forest, IL. | Health Technology |
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
Levo Therapeutics, Inc.
Levo Therapeutics, Inc. BiotechnologyHealth Technology Levo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Glenview, IL. | Health Technology |
